Expert InsightsFree Webinar – Intact Protein Analysis in a Multi-User/Multi-Project Walk-Up Environment
Industry NewsMinoryx Therapeutics Announces Dosing of First Patient in ADVANCE Trial, a Phase 2/3 Clinical Study of MIN-102 in Patients with Adrenomyeloneuropathy (AMN)
Editorial ArticleVote for the Best New Drug Discovery & Development Product of 2017 in the Scientists’ Choice Awards
Industry NewsAnticancer Agent Lenvatinib Designated for Priority Review and Approval by CFDA for Hepatocellular Carcinoma
Product NewsRyzodeg Shown to Significantly Reduce the Risk of Low Blood Sugar in People with Type 2 Diabetes Who Fast During Ramadan
Expert InsightsWebinar Highlights - Label-Free High-Throughput MALDI TOF Mass Spectrometry in Drug Discovery